- Home
- RLYB vs KXIN Comparison
RLYB vs KXIN Comparison
Compare RLYB & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- KXIN
- Stock Information
- Founded
- RLYB 2018
- KXIN 2015
- Country
- RLYB United States
- KXIN China
- Employees
- RLYB N/A
- KXIN N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- RLYB Health Care
- KXIN Consumer Discretionary
- Exchange
- RLYB Nasdaq
- KXIN Nasdaq
- Market Cap
- RLYB 14.4M
- KXIN 13.0M
- IPO Year
- RLYB 2021
- KXIN N/A
- Fundamental
- Price
- RLYB $0.35
- KXIN $0.91
- Analyst Decision
- RLYB Hold
- KXIN
- Analyst Count
- RLYB 3
- KXIN 0
- Target Price
- RLYB $15.00
- KXIN N/A
- AVG Volume (30 Days)
- RLYB 329.4K
- KXIN 53.4K
- Earning Date
- RLYB 08-07-2025
- KXIN 01-01-0001
- Dividend Yield
- RLYB N/A
- KXIN N/A
- EPS Growth
- RLYB N/A
- KXIN N/A
- EPS
- RLYB N/A
- KXIN N/A
- Revenue
- RLYB $848,000.00
- KXIN N/A
- Revenue This Year
- RLYB N/A
- KXIN N/A
- Revenue Next Year
- RLYB N/A
- KXIN N/A
- P/E Ratio
- RLYB N/A
- KXIN N/A
- Revenue Growth
- RLYB N/A
- KXIN N/A
- 52 Week Low
- RLYB $0.22
- KXIN $0.64
- 52 Week High
- RLYB $1.54
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- RLYB 53.64
- KXIN 52.51
- Support Level
- RLYB $0.30
- KXIN $0.84
- Resistance Level
- RLYB $0.38
- KXIN $0.96
- Average True Range (ATR)
- RLYB 0.04
- KXIN 0.05
- MACD
- RLYB 0.00
- KXIN 0.00
- Stochastic Oscillator
- RLYB 49.29
- KXIN 63.64
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.